Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

18.69 +0.08 (+0.41%)
Delayed Quote Updated: 9:56 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
News headline image
Nasdaq Gains 1%; Charles Schwab Earnings Top Views ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Why Omeros Corporation (OMER) Shares Are Nosediving ↗
Omeros Corp (NASDAQ: OMER) shares are trading lower by 47% to $1.20 during Monday's pre-market session. 
Via Benzinga
News headline image
Earnings Preview: Omeros ↗
 
Via Benzinga
News headline image
Why Shares of Omeros Dropped on Monday ↗
The clinical-stage biopharmaceutical released trials data through a presentation. 
Via The Motley Fool
News headline image
Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
From Omeros Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Omeros: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Preview: Omeros ↗
 
Via Benzinga
News headline image
Omeros's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Omeros Corporation Reports Second Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
From Omeros Corporation
Via Business Wire
News headline image
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
News headline image
Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Monday. Here are some big stocks recording losses in today’s session. Beneficient (NASDAQ: BENF) shares fell 17% to... 
Via Benzinga
News headline image
Why Omeros Stock Bolted Higher This Week ↗
A $200 million milestone payment sparked a rally in the biopharma's shares this week. 
Via The Motley Fool
News headline image
Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Reports First Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
From Omeros Corporation
Via Business Wire
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry
EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market... 
Via Benzinga
News headline image
Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program
From Omeros Corporation
Via Business Wire
News headline image
Short Interest Sector Focus: Healthcare Sector ↗
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
News headline image
Omeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Confirms Absence of Financial Exposure to Silicon Valley Bank
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023
From Omeros Corporation
Via Business Wire
News headline image
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.